Consensus Claritev Corporation

Stocks

CTEV

US62548M2098

Business Support Services

Market Closed - NYSE 23:00:02 14/10/2026 +03			5-day change	1st Jan Change
23.94 ^USD	+0.93%		-0.62%	-44.00%

09-22	Claritev Corporation Is Selected By General Dynamics Information Technology To Support CDC?s World Trade Center Health Program	CI
09-15	Claritev Corporation Announces Appointment of Ben Letham as Class I Director and to the Risk Committee, Effective September 14, 2026	CI

Evolution of the Average Target: Claritev Corporation

Evolution of the Target Price: Claritev Corporation

Changes in Analyst Recommendations: Claritev Corporation

4473973f078884738c6.0uwGHqXrlSruxFVA8c_5Bjvp1S1cpG662kFqztTlmfU.mYM3UsiE73DaoDB5oI2RVXau4BsMwTjvnSsMm62_3KTljmtsy6z4YayJFA~0ccc778d276beb4ab19ff95e8679dc52

Analysts' recommendations: Claritev Corporation

05-29	Canaccord Genuity Initiates Claritev at Buy With $32 Price Target	MT
01-12	Guggenheim Initiates Coverage on Claritev With Buy Rating, $43 Price Target	MT
01-09	Wells Fargo Initiates Claritev Corp at Equalweight With $33 Price Target	MT
21/10/25	Claritev Shares Rise After Upgrade From Citigroup	MT
21/10/25	Citigroup Upgrades Claritev to Buy From Neutral, $55 Price Target	MT
29/05/25	Claritev Shares Rise After Upgrade From Piper Sandler	MT
29/05/25	Piper Sandler Upgrades Claritev to Overweight From Neutral, Adjusts Price Target to $44 From $19	MT
26/06/24	Piper Sandler Initiates MultiPlan at Neutral With $2 Price Target	MT
08/03/23	Citigroup Adjusts Price Target on MultiPlan to $1.25 From $2, Keeps Neutral Rating	MT
18/01/23	Barclays Adjusts Price Target on MultiPlan to $1 From $3, Maintains Equal-Weight Rating	MT
13/12/22	Citigroup Downgrades MultiPlan to Neutral From Buy, Cuts Price Target to $2 From $3	MT
16/11/22	Goldman Sachs Adjusts Price Target on MultiPlan to $2.05 From $5.50, Maintains Neutral Rating	MT
09/11/22	Citigroup Adjusts Price Target on MultiPlan to $3 From $6, Maintains Buy Rating	MT
12/07/22	Goldman Sachs Starts MultiPlan at Neutral With $6.50 Price Target	MT
20/12/21	Citigroup Adjusts MultiPlan's Price Target to $7 from $9, Keeps Buy Rating	MT
11/11/21	Barclays Adjusts MultiPlan's Price Target to $6 From $7, Keeps Equal-Weight Rating	MT
20/08/21	MultiPlan : Tigress Research Initiates Coverage of MultiPlan with Buy Rating, $9 Price Target	MT
07/04/21	MultiPlan : B. Riley Starts MultiPlan at Buy with $10 Price Target; Expects Material Revenue, Earnings Growth Ahead	MT
19/03/21	MultiPlan : Barclays Starts MultiPlan at Equalweight with $7 Price Target	MT
16/11/20	MultiPlan : Citigroup Starts MultiPlan at Buy With $10 Price Target	MT

More recommendations

Data Processing Services

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	CLARITEV CORPORATION					+93.93%
	VISA, INC.					+6.16%
	CINTAS CORPORATION					+5.78%
	UNITED RENTALS, INC.					+19.36%
	NEBIUS GROUP					+37.1%
	PAYPAL HOLDINGS, INC.					+1.22%
	BLOCK, INC.					+27.7%
	SUNBELT RENTALS HOLDINGS, INC.					+14.53%
	CORPAY, INC.					+15.51%
	FISERV, INC.					+26.7%
	Average					+24.80%
	Weighted average by Cap.					+10.14%